150 related articles for article (PubMed ID: 12627044)
1. Comparison of the difference in histopathology and cell cycle kinetics among the postmenopausal endometrium treated with different progestins in sequential-combined hormone replacement therapy.
Chang TC; Chen M; Lien YR; Chen RJ; Chow SN
Menopause; 2003; 10(2):172-8. PubMed ID: 12627044
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle analysis and detection of proliferative cell nuclear antigen of the endometrium after hormone replacement therapy.
Chow SN; Chen M; Chen PJ; Chen RJ; Chien CH
Maturitas; 2001 Sep; 39(3):227-37. PubMed ID: 11574182
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
4. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
Pickar JH; Yeh I; Wheeler JE; Cunnane MF; Speroff L
Fertil Steril; 2001 Jul; 76(1):25-31. PubMed ID: 11438315
[TBL] [Abstract][Full Text] [Related]
5. The endometrial nucleolar channel system as an indicator of progestin potency in HRT.
Ryder TA; Mobberley MA; Whitehead MI
Maturitas; 1995 Jun; 22(1):31-6. PubMed ID: 7666814
[TBL] [Abstract][Full Text] [Related]
6. The effects of progesterone and progestins on endometrial proliferation.
Moyer DL; Felix JC
Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the potency of orally administered progestins in women.
King RJ; Whitehead MI
Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential therapy.
Exacoustòs C; Lello S; Caporale E; Minghetti MC; Angelozzi D; Arduini D; Romanini C
Fertil Steril; 1999 Mar; 71(3):536-43. PubMed ID: 10065794
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
AinMelk Y
Fertil Steril; 1996 Dec; 66(6):962-8. PubMed ID: 8941062
[TBL] [Abstract][Full Text] [Related]
10. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
Gibbons WE; Thorneycroft IH
J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
[TBL] [Abstract][Full Text] [Related]
11. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Archer DF; Pickar JH; Bottiglioni F
Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
[TBL] [Abstract][Full Text] [Related]
12. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
13. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
[TBL] [Abstract][Full Text] [Related]
15. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
[TBL] [Abstract][Full Text] [Related]
16. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
[TBL] [Abstract][Full Text] [Related]
17. Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
Nand SL; Webster MA; Baber R; O'Connor V
Obstet Gynecol; 1998 May; 91(5 Pt 1):678-84. PubMed ID: 9572210
[TBL] [Abstract][Full Text] [Related]
18. Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens.
Heikkinen J; Vaheri R; Kainulainen P; Timonen U
Osteoporos Int; 2000; 11(11):929-37. PubMed ID: 11193245
[TBL] [Abstract][Full Text] [Related]
19. Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study.
Pinto AB; Binder EF; Kohrt WM; Bronder DR; Williams DB
Am J Obstet Gynecol; 2003 Jul; 189(1):11-5. PubMed ID: 12861131
[TBL] [Abstract][Full Text] [Related]
20. Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone.
Ferenczy A; Gelfand MM
Maturitas; 1997 Apr; 26(3):219-26. PubMed ID: 9147354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
